{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:40:55Z","timestamp":1788871255897,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Merck Sharp & Dohme (I.A.) Corp. Taiwan Branch"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.vaccine.2015.01.085","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T13:39:48Z","timestamp":1423661988000},"page":"1515-1517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The immunogenicity and safety of zoster vaccine in Taiwanese adults"],"prefix":"10.1016","volume":"33","author":[{"given":"Chien-An","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Kung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.085_bib0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"Review: the neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.01.085_bib0110","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1086\/522152","article-title":"The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine","volume":"197","author":"Schmader","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4161\/hv.7.10.16480","article-title":"Immunogenicity and safety of ZOSTAVAX((R)) approaching expiry potency in individuals aged \u226550 years","volume":"7","author":"Arnou","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0120","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2015.01.085_bib0125","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1086\/522159","article-title":"Vaccination against Herpes Zoster and Postherpetic Neuralgia","volume":"197","author":"Oxman","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0130","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"issue":"RR-5","key":"10.1016\/j.vaccine.2015.01.085_bib0135","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0140","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s40265-013-0088-1","article-title":"Shingles (herpes zoster) vaccine (zostavax((R))): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged \u226550 years","volume":"73","author":"Keating","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0145","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","article-title":"Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors","volume":"27","author":"Lu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0150","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.vaccine.2008.10.047","article-title":"Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly","volume":"27","author":"Opstelten","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0155","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jmv.1890320310","article-title":"Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen","volume":"32","author":"Wasmuth","year":"1990","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0264-410X(96)00107-7","article-title":"Comparison of gpELISA and neutralizing antibody responses to Oka\/Merck live varicella vaccine (Varivax) in children and adults","volume":"15","author":"Krah","year":"1997","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2015.01.085_bib0165","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiu279","article-title":"Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine: demonstrated via the vaccine efficacy curve","volume":"210","author":"Gilbert","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CVI.00310-07","article-title":"A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax","volume":"15","author":"Gilderman","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1128\/CVI.00407-08","article-title":"Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older","volume":"16","author":"Sutradhar","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0180","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1532-5415.2007.01397.x","article-title":"Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older","volume":"55","author":"Kerzner","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0185","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2340\/00015555-0729","article-title":"Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006","volume":"89","author":"Jih","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0190","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.vaccine.2009.11.029","article-title":"Disease burden and epidemiology of herpes zoster in pre-vaccine Taiwan","volume":"28","author":"Lin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0195","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.vaccine.2006.10.027","article-title":"Safety and tolerability of a high-potency zoster vaccine in adults \u226550 or years of age","volume":"25","author":"Tyring","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.085_bib0200","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.vaccine.2006.11.011","article-title":"Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults","volume":"25","author":"Macaladad","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T04:26:43Z","timestamp":1537849603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15001528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":20,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0264410X15001528"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunogenicity and safety of zoster vaccine in Taiwanese adults","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}